非特異的免疫療法
免疫療法
免疫療法（めんえきりょうほう）
免疫療法
出典: フリー百科事典『ウィキペディア（Wikipedia）』 (2022/04/17 14:14 UTC 版)
免疫療法（めんえきりょうほう、英: Immunotherapy）は、「免疫応答を誘導、増強、または抑制することによる疾患の治療」である[1]。免疫療法は、免疫応答を誘発または増幅する免疫療法、免疫応答を抑制する免疫療法に分類できる。
- ^ “immunotherapies definition”. Dictionary.com. 2009年6月2日閲覧。
- ^ Masihi KN (July 2001). “Fighting infection using immunomodulatory agents”. Expert Opin. Biol. Ther. 1 (4): 641–53. doi:10.1517/14712598.1.4.641. PMID 11727500.
- ^ “Prolonged disease-free period in patients with advanced epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes”. Clin. Cancer Res. 1 (5): 501–7. (May 1995). PMID 9816009.
- ^ “A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma”. Cancer 80 (1): 42–9. (July 1997). doi:10.1002/(SICI)1097-0142(19970701)80:1<42::AID-CNCR6>3.0.CO;2-H. PMID 9210707.
- ^ “Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial”. Lancet 356 (9232): 802–7. (September 2000). doi:10.1016/S0140-6736(00)02654-4. PMID 11022927.
- ^ “Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced gastric cancer: a randomized trial”. Clin. Cancer Res. 8 (6): 1767–71. (June 2002). PMID 12060615.
- ^ “Preclinical ex vivo expansion of G-CSF-mobilized peripheral blood stem cells: effects of serum-free media, cytokine combinations and chemotherapy”. Eur. J. Haematol. 74 (2): 128–35. (February 2005). doi:10.1111/j.1600-0609.2004.00343.x. PMID 15654904.
- ^ “Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up”. Eur. Urol. 56 (2): 260–5. (August 2009). doi:10.1016/j.eururo.2009.04.009. PMID 19395154.
- ^ “Treatment of vulvar intraepithelial neoplasia with topical imiquimod”. N. Engl. J. Med. 358 (14): 1465–73. (April 2008). doi:10.1056/NEJMoa072685. PMID 18385498.
- ^ “Treatment of vaginal intraepithelial neoplasia (primarily low grade) with imiquimod 5% cream”. J Low Genit Tract Dis 7 (4): 290–3. (October 2003). doi:10.1097/00128360-200310000-00011. PMID 17051086.
- ^ “Immunotherapy for head and neck cancer”. Oral Oncol. 45 (9): 747–51. (September 2009). doi:10.1016/j.oraloncology.2009.02.009. PMID 19442565.
- ^ “Extracorporeal photoimmunotherapy-photopheresis”. Front. Biosci. 14 (14): 4769–77. (2009). doi:10.2741/3566. PMID 19273388.
- ^ “Melanoma and immunotherapy”. Hematol. Oncol. Clin. North Am. 23 (3): 547–64, ix–x. (June 2009). doi:10.1016/j.hoc.2009.03.009. PMID 19464602.
- ^ “Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic anti tumor effects”. J. Biomed. Sci. 16 (1): 49. (2009). doi:10.1186/1423-0127-16-49. PMC 2705346. PMID 19473507.
- ^ “[Recurrent respiratory papillomatosis: indication for HPV vaccination?]” (German). Dtsch. Med. Wochenschr. 134 Suppl 2: S100–2. (April 2009). doi:10.1055/s-0029-1220219. PMID 19353471.
- ^ “Adoptive immunotherapy of lung cancer with immobilized anti-TCRgammadelta antibody-expanded human gammadelta T-cells in peripheral blood”. Cancer Biol. Ther. 8 (16): 1540–9. (August 2009). doi:10.4161/cbt.8.16.8950. PMID 19471115.
- ^ Gao, Daiqing (2014-01-01). “Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients”. PloS One 9 (4): e93886. doi:10.1371/journal.pone.0093886. ISSN 1932-6203. PMC 3974849. PMID 24699863.
- ^ “Efficient activation of LRH-1-specific CD8+ T-cell responses from transplanted leukemia patients by stimulation with P2X5 mRNA-electroporated dendritic cells”. J. Immunother. 32 (6): 539–51. (2009). doi:10.1097/CJI.0b013e3181987c22. PMID 19483655.
- ^ “Immunotherapy for the treatment of prostate cancer”. Nature Reviews Clinical Oncology 8 (9): 551–61. (September 2011). doi:10.1038/nrclinonc.2011.72. PMID 21606971.
- ^ “Adoptive cell transfer: a clinical path to effective cancer immunotherapy”. Nature Reviews Cancer 8 (4): 299–308. (April 2008). doi:10.1038/nrc2355. PMC 2553205. PMID 18354418.
- ^ “CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells”. Journal of Immunology 174 (5): 2591–601. (March 2005). doi:10.4049/jimmunol.174.5.2591. PMC 1403291. PMID 15728465.
- ^ “Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells”. J. Exp. Med. 202 (7): 907–12. (October 2005). doi:10.1084/jem.20050732. PMC 1397916. PMID 16203864.
- ^ “T cell homeostatic proliferation elicits effective antitumor autoimmunity”. J. Clin. Invest. 110 (2): 185–92. (July 2002). doi:10.1172/JCI15175. PMC 151053. PMID 12122110.
- ^ “Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens”. J. Clin. Oncol. 26 (32): 5233–9. (November 2008). doi:10.1200/JCO.2008.16.5449. PMC 2652090. PMID 18809613.
- ^ “Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes”. Science 298 (5594): 850–4. (October 2002). doi:10.1126/science.1076514. PMC 1764179. PMID 12242449.
- ^ “Efficacy of adoptive cell transfer of tumor-infiltrating lymphocytes after lymphopenia induction for metastatic melanoma”. J. Immunother. 35 (8): 615–20. (October 2012). doi:10.1097/CJI.0b013e31826e8f5f. PMID 22996367.
- ^ “Autologous immune enhancement therapy in recurrent ovarian cancer with metastases: a case report”. Case Rep Oncol 5 (1): 114–8. (January 2012). doi:10.1159/000337319. PMC 3364094. PMID 22666198.
- ^ “Natural killer cells inhibit hepatitis C virus expression”. J. Leukoc. Biol. 76 (6): 1171–9. (December 2004). doi:10.1189/jlb.0604372. PMID 15339939.
- ^ “Possibility of adoptive immunotherapy with peripheral blood-derived CD3⁻CD56+ and CD3+CD56+ cells for inducing antihepatocellular carcinoma and antihepatitis C virus activity”. J. Immunother. 34 (2): 129–38. (March 2011). doi:10.1097/CJI.0b013e3182048c4e. PMID 21304407.
- ^ “Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections”. Int. Rev. Immunol. 27 (3): 93–110. (2008). doi:10.1080/08830180801911743. PMID 18437601.
- ^ “alpha-Interferon treatment of patients with chronic fatigue syndrome”. Immunol. Invest. 25 (1–2): 153–64. (1996). doi:10.3109/08820139609059298. PMID 8675231.
- ^ “Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome”. Clin. Infect. Dis. 18 Suppl 1: S157–9. (January 1994). doi:10.1093/clinids/18.Supplement_1.S157. PMID 8148445.
- ^ “Killing of human Herpes virus 6-infected cells by lymphocytes cultured with interleukin-2 or -12”. Pediatr Int 42 (6): 631–6. (December 2000). doi:10.1046/j.1442-200x.2000.01315.x. PMID 11192519.
- ^ “Cancer regression in patients after transfer of genetically engineered lymphocytes”. Science 314 (5796): 126–9. (October 2006). doi:10.1126/science.1129003. PMC 2267026. PMID 16946036.
- ^ “Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1”. N. Engl. J. Med. 358 (25): 2698–703. (June 2008). doi:10.1056/NEJMoa0800251. PMC 3277288. PMID 18565862.
- ^ “2008 Symposium Program & Speakers”. Cancer Research Institute. 2008年10月15日時点のオリジナル[リンク切れ]よりアーカイブ。2017年3月27日閲覧。
- ^ http://www.telegraph.co.uk/earth/main.jhtml?xml=/earth/2008/06/18/scicanc118.xml[要文献特定詳細情報]
- ^ “The immune tolerance network: a new paradigm for developing tolerance-inducing therapies”. The Journal of Allergy and Clinical Immunology 110 (1): 17–23. (July 2002). doi:10.1067/mai.2002.124258. PMID 12110811.
- ^ “Long-term clinical efficacy of grass-pollen immunotherapy”. N. Engl. J. Med. 341 (7): 468–75. (August 1999). doi:10.1056/NEJM199908123410702. PMID 10441602.
- ^ “Clinical Trials Search Results - Stanford University School of Medicine”. 2016年4月3日閲覧。
- ^ “Association between parasite infection and immune responses in multiple sclerosis”. Annals of Neurology 61 (2): 97–108. (February 2007). doi:10.1002/ana.21067. PMID 17230481.
- ^ “A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors”. Gut 55 (1): 136–7. (January 2006). doi:10.1136/gut.2005.079129. PMC 1856386. PMID 16344586.
- ^ “An update on the use of helminths to treat Crohn's and other autoimmunune diseases”. Parasitol. Res. 104 (2): 217–21. (January 2009). doi:10.1007/s00436-008-1297-5. PMID 19050918.
- ^ “[Helminths and inflammatory bowel diseases]” (French). Gastroenterol. Clin. Biol. 32 (12): 1064–74. (December 2008). doi:10.1016/j.gcb.2008.04.030. PMID 18619749.
- ^ “Parasitic worms and inflammatory diseases”. Parasite Immunol. 28 (10): 515–23. (October 2006). doi:10.1111/j.1365-3024.2006.00879.x. PMC 1618732. PMID 16965287.
- ^ “Human Hookworm Infection in the 21st Century”. Advances in Parasitology 58: 197–288. (2004). doi:10.1016/S0065-308X(04)58004-1. ISBN 9780120317585. PMC 2268732. PMID 15603764.
- ^ “Necator americanus infection: a possible cause of altered dendritic cell differentiation and eosinophil profile in chronically infected individuals”. PLoS Negl Trop Dis 3 (3): e399. (2009). doi:10.1371/journal.pntd.0000399. PMC 2654967. PMID 19308259.
- ^ “Review series on helminths, immune modulation and the hygiene hypothesis: mechanisms underlying helminth modulation of dendritic cell function”. Immunology 126 (1): 28–34. (January 2009). doi:10.1111/j.1365-2567.2008.03008.x. PMC 2632707. PMID 19120496.
- ^ “Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions”. J. Exp. Med. 206 (6): 1395–408. (June 2009). doi:10.1084/jem.20082779. PMC 2715056. PMID 19468064.
[続きの解説]
「免疫療法」の続きの解説一覧
- 1 免疫療法とは
- 2 免疫療法の概要
- 3 寄生虫を用いた療法
免疫療法
出典: フリー百科事典『ウィキペディア（Wikipedia）』 (2021/03/29 21:21 UTC 版)
ステロイド、免疫抑制薬、血漿交換、免疫グロブリン療法いずれも有用と考えられている。しかし全ての症例に免疫療法が奏効するわけではない。
※この「免疫療法」の解説は、「糖尿病性神経障害」の解説の一部です。
「免疫療法」を含む「糖尿病性神経障害」の記事については、「糖尿病性神経障害」の概要を参照ください。
ウィキペディア小見出し辞書の「免疫療法」の項目はプログラムで機械的に意味や本文を生成しているため、不適切な項目が含まれていることもあります。ご了承くださいませ。 お問い合わせ。
「免疫療法」の例文・使い方・用例・文例
- 免疫療法のページへのリンク
